A revolution in the treatment of non-Hodgkin's lymphoma

Cancer Biother Radiopharm. 1998 Aug;13(4):213-23. doi: 10.1089/cbr.1998.13.213.


The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunotherapy*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Lymphoma, Non-Hodgkin / therapy*
  • Radioimmunotherapy*


  • Antibodies, Monoclonal